{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:25Z","timestamp":1790511025697,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Basilea, Gilead Sciences, Merck"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jinf.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T01:17:24Z","timestamp":1508894244000},"page":"20-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines"],"prefix":"10.1016","volume":"76","author":[{"given":"Malgorzata","family":"Mikulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ceppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bochud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"De La Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubos","family":"Drgona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Girmenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Heldal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannick Helweg","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Klyasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Koskuenvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Padoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Racil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie Rizzi","family":"Puechal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Sinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Sousa","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Styczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Therese","family":"Witschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jinf.2017.10.009_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejcsup.2007.06.002","article-title":"Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients","author":"Bucaneve","year":"2007","journal-title":"Eur J Cancer Suppl"},{"issue":"10","key":"10.1016\/j.jinf.2017.10.009_bib0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"NEJM"},{"issue":"10","key":"10.1016\/j.jinf.2017.10.009_bib0020","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","article-title":"Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas","volume":"353","author":"Cullen","year":"2005","journal-title":"NEJM"},{"issue":"12 Pt 1","key":"10.1016\/j.jinf.2017.10.009_bib0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajic.2005.03.009","article-title":"Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon","volume":"33","author":"Kanafani","year":"2005","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10096-004-1264-8","article-title":"Prevalence and risk factors of extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae in an Israeli long-term care facility","volume":"24","author":"Mendelson","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0055","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","article-title":"Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients","volume":"23","author":"Colodner","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004386.pub2","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter-Gvili","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/joc.2005.17.3.251","article-title":"Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines","volume":"17","author":"Fadda","year":"2005","journal-title":"J Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2017.10.009_bib0075","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10096-002-0837-7","article-title":"Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals","volume":"21","author":"Luzzaro","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.jinf.2017.10.009_bib0085","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/sim.1040","article-title":"Advanced methods in meta-analysis: multivariate approach and meta-regression","volume":"21","author":"van Houwelingen","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0105","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10096-007-0397-y","article-title":"Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials","volume":"27","author":"Imran","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jinf.2014.02.013","article-title":"Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials","volume":"69","author":"Kimura","year":"2014","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","article-title":"Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis","volume":"59","author":"Gafter-Gvili","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1b","key":"10.1016\/j.jinf.2017.10.009_bib0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","article-title":"Use of antibacterial prophylaxis for patients with neutropenia. Australian consensus guidelines 2011 steering committee","volume":"41","author":"Slavin","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.jinf.2017.10.009_bib0135","doi-asserted-by":"crossref","first-page":"e5368","DOI":"10.1136\/bmj.e5368","article-title":"Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance","volume":"345","author":"Phillips","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0140","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"Neumann","year":"2013","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.jinf.2017.10.009_bib0150","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2012.0146","article-title":"Prevention and treatment of cancer-related infections","volume":"10","author":"Baden","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 5","key":"10.1016\/j.jinf.2017.10.009_bib0155","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.009_bib0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2011.10.009","article-title":"Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial","volume":"39","author":"Vehreschild","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2017.10.009_bib0170","author":"ECDC"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0175","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","article-title":"Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy","volume":"32","author":"Laoprasopwattana","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.jinf.2017.10.009_bib0180","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/annonc\/mdm112","article-title":"Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia","volume":"18","author":"Halim","year":"2007","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.009_bib0185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1155\/2004\/947026","article-title":"Uropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis","volume":"15","author":"McIsaac","year":"2004","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jinf.2017.10.009_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-0711-3-14","article-title":"Emerging resistance among bacterial pathogens in the intensive care unit\u2013a European and North American surveillance study (2000\u20132002","volume":"3","author":"Jones","year":"2004","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bmt.1705591","article-title":"The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit","volume":"39","author":"Craig","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2478\/v10039-012-0004-z","article-title":"Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience","volume":"57","author":"Wolska","year":"2012","journal-title":"Adv Med Sci"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.009_bib0205","first-page":"345","volume":"65","author":"Chlabicz","year":"2011","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.jinf.2017.10.009_bib0210","author":"EARSS"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.009_bib0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/tid.12035","article-title":"Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit","volume":"15","author":"Cumpston","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-13-356","article-title":"Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance","volume":"13","author":"Garnica","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.009_bib0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"Schito","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2012.04.007","article-title":"Antimicrobial resistance among gram-negative bacilli isolated from Latin America: results from SENTRY antimicrobial surveillance program (Latin America, 2008\u20132010)","volume":"73","author":"Gales","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0235","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0240","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","article-title":"Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia","volume":"34","author":"Felsenstein","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10096-007-0428-8","article-title":"Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit","volume":"27","author":"Saito","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2017.10.009_bib0250","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijantimicag.2004.02.001","article-title":"Bacterial resistance to antimicrobials in urinary isolates","volume":"24","author":"Muratani","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.009_bib0255","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2005.02.009","article-title":"Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002","volume":"52","author":"Yamaguchi","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0260","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/bmt.2009.344","article-title":"Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning","volume":"45","author":"Kanda","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0265","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.ijid.2010.12.010","article-title":"Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies","volume":"15","author":"Chong","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0270","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10156-012-0419-2","article-title":"Sensitivities of major causative organisms isolated from patients with acute uncomplicated cystitis against various antibacterial agents: results of subanalysis based on the presence of menopause","volume":"18","author":"Matsumoto","year":"2012","journal-title":"J Infect Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2017.10.009_bib0275","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10096-011-1489-2","article-title":"The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience","volume":"31","author":"Sohn","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"46","key":"10.1016\/j.jinf.2017.10.009_bib0280","first-page":"68","article-title":"A study of antimicrobial sensitivity to the causative organism of urinary tract infection","volume":"1","author":"Song","year":"2005","journal-title":"Korean J Urol"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3346\/jkms.2004.19.1.8","article-title":"Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001","volume":"19","author":"Lee","year":"2004","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0290","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/ejh.12345","article-title":"Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia","volume":"93","author":"Verlinden","year":"2014","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.jinf.2017.10.009_bib0295","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/jac\/dkq286","article-title":"Antibiotic susceptibility of unselected uropathogenic escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval","volume":"65","author":"den Heijer","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2017.10.009_bib0300","author":"ECDC. European Centre for Disease Prevention and Control"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","article-title":"Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial","volume":"106","author":"Karp","year":"1987","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jinf.2017.10.009_bib0310","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(98)00158-8","article-title":"Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY antimicrobial surveillance program, 1997","volume":"35","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0732-8893(94)90033-7","article-title":"Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone resistance surveillance group","volume":"19","author":"Jones","year":"1994","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2017.10.009_bib0325","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/502252","article-title":"Resistance in enterobacteriaceae: results of a multicenter surveillance study, 1995\u20132000","volume":"24","author":"Friedland","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0330","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00007890-199103000-00017","article-title":"Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation","volume":"51","author":"Lew","year":"1991","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0335","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcp\/106.3.275","article-title":"1995 ASCP susceptibility testing group","volume":"106","author":"United States geographic bacteria susceptibility patterns","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2169\/internalmedicine.31.319","article-title":"Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy","volume":"31","author":"Tsutani","year":"1992","journal-title":"Internal medicine"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0345","first-page":"387","article-title":"Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin\u2013Surveillance Group]","volume":"53","author":"Yamaguchi","year":"2000","journal-title":"Jpn J Antibiot"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.009_bib0350","first-page":"401","article-title":"Prophylaxis with fluoroquinolones in patients with neutropenia]","volume":"53","author":"Brodsky","year":"1993","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0355","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1590\/S1020-49891999000900002","article-title":"[Monitoring antibiotic resistance in Argentina. The WHONET program, 1995\u20131996]","volume":"6","author":"Rossi","year":"1999","journal-title":"Rev Panam Salud Publica"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0360","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/AAC.37.3.474","article-title":"Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The enoxacin prophylaxis study group","volume":"37","author":"Talbot","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.009_bib0365","first-page":"369","article-title":"[Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study]","volume":"42","author":"Thabaut","year":"1994","journal-title":"Pathol Biol (Paris)"},{"issue":"9","key":"10.1016\/j.jinf.2017.10.009_bib0370","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2169\/internalmedicine.32.710","article-title":"Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B","volume":"32","author":"Yamada","year":"1993","journal-title":"Internal medicine"},{"issue":"32","key":"10.1016\/j.jinf.2017.10.009_bib0375","first-page":"1745","article-title":"[Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study]","volume":"29","author":"Thomas","year":"2000","journal-title":"Presse Med"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2017.10.009_bib0380","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/clinids\/24.Supplement_1.S67","article-title":"Trends in bacterial resistance to fluoroquinolones","volume":"24","author":"Acar","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2017.10.009_bib0385","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1198-743x.2001.00322.x","article-title":"Trends in quinolone susceptibility of enterobacteriaceae among inpatients of a large university hospital: 1992\u201398","volume":"7","author":"Robert","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0390","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1469-0691.2002.00393.x","article-title":"Susceptibility of enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France","volume":"8","author":"Sirot","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2017.10.009_bib0395","first-page":"40","article-title":"Fluoroquinolone prophylaxis for bacterial infections in neutropenic patients with hematologic malignancies","volume":"43","author":"Nenova","year":"2001","journal-title":"Folia Med (Plovdiv)"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2807\/esm.10.06.00548-en","article-title":"Surveillance of antimicrobial resistance in Bulgaria\u2013a synopsis from BulSTAR 2003","volume":"10","author":"Petrov","year":"2005","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085210","article-title":"Clinical impact of fluoroquinolone-resistant escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis","volume":"9","author":"Chong","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jinf.2017.10.009_bib0410","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.10.009_bib0415","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbmt.2014.12.006","article-title":"Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis","volume":"21","author":"Miles-Jay","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1016\/j.jinf.2017.10.009_bib0420","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archinternmed.2011.374","article-title":"Etiology of febrile episodes in patients with acute myeloid leukemia: results from the hema e-chart registry","volume":"171","author":"Pagano","year":"2011","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.jinf.2017.10.009_bib0425","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European conference on infections in leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jinf.2017.10.009_bib0430","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bmt.2014.231","article-title":"Infections by carbapenem-resistant klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy","volume":"50","author":"Girmenia","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2017.10.009_bib0435","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2010.036640","article-title":"Multidrug resistant pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies","volume":"96","author":"Trecarichi","year":"2011","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.jinf.2017.10.009_bib0440","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3748\/wjg.v20.i21.6602","article-title":"Hematologic diseases: high risk of clostridium difficile associated diarrhea","volume":"20","author":"Gweon","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jinf.2017.10.009_bib0445","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3324\/haematol.2013.091769","article-title":"The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients","volume":"98","author":"Gyssens","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jinf.2017.10.009_bib0450","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among enterobacteriaceae in Europe","volume":"18","author":"Canton","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jinf.2017.10.009_bib0455","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.2016.11764","article-title":"Antimicrobial resistance","volume":"316","author":"Marston","year":"2016","journal-title":"JAMA"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317303225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317303225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:29Z","timestamp":1759008329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317303225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0163445317303225"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.10.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}